GPT and kidney disorder: Initial clinical laboratory values differed significantly between PLWDH and controls, as PLWDH were more likely to have low platelets (mPR, 1.30 [95% CI, 1.12–1.51]), elevated BUN (mPR, 1.17 [95% CI, 1.08–1.28]), and creatinine (mPR, 1.31 [95% CI, 1.18–1.44]), but less likely to have elevated glucose (mPR, 0.87 [95% CI, 0.83–0.91]), AST (mPR, 0.94 [95% CI, 0.87–1.01]), and ALT (mPR, 0.79 [95% CI, 0.70–0.89]), consistent with observed histories of renal disease and diabetes mellitus (Table 3).